-
ASCO 2024| Meta-Analysis of Short-Term Recurrence Risk in HR+/HER2- Early Breast Cancer Patients Undergoing Endocrine Therapy
Multiple studies have demonstrated that both lymph node-positive and lymph node-negative stage II or III HR+/HER2- early breast cancer patients are at risk of recurrence, and the recurrence rate gradually increases over time. At the 2024 ASCO conference, a study conducted a systematic literature review and meta-analysis to evaluate the 3-year and 5-year recurrence risk…
-
Dr. Qiang Liu: Can Triple-Negative Breast Cancer Be Treated Without Chemotherapy?—Exploring Precision Medicine Guided by Biomarkers in Breast Cancer
In recent years, significant advancements have been made in the treatment of triple-negative breast cancer (TNBC), particularly in the field of biomarker research. To delve deeper into this, Cancer Outlook invited Dr. Qiang Liu from Sun Yat-sen Memorial Hospital, Sun Yat-sen University to provide an in-depth analysis of two recent landmark studies. These studies explore…
-
The 5th Lymphoma & Myeloma Immunotherapy and Targeted Therapy Conference | Dr. Kai Fu Discusses Research Progress and a New Prognostic Model in the North American Mantle Cell Lymphoma Program (NAMCLP)
On July 20, 2024, the 5th Lymphoma & Myeloma Immunotherapy and Targeted Therapy Conference, part of the Gaobo Medical Academic Conference, was successfully held in Beijing. With the core themes of “Precision, Integration, and Innovation,” the conference closely followed the latest developments and cutting-edge topics from the 29th Annual Congress of the European Hematology Association…
-
International Lung Cancer Conference | Dr. Yuehong Wang: Exploring a New Model for Comprehensive Lung Cancer Management in the AI Era
At the International Lung Cancer Conference (CLC 2024) held from August 9-11, Dr. Yuehong Wang from The First Affiliated Hospital, Zhejiang University School of Medicine delivered a keynote presentation titled “Exploring a New Model for Comprehensive Lung Cancer Management in the AI Era.” This article provides a brief overview of her report.
-
International Lung Cancer Conference | Dr. Nan Bi: Optimizing MRIgART Processes to Improve the Treatment of Brain Metastases in Lung Cancer
Radiation therapy plays a crucial role in the treatment of brain metastases from lung cancer. At the recent International Lung Cancer Conference (CLC 2024), Dr. Nan Bi from the Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College, delivered a keynote presentation titled “Advances in Precision Radiotherapy for Brain Metastases in…
-
Highlights of the Zhongshan-Specific Colorectal Cancer Forum with Emphasis on Precision Diagnosis, Treatment, and Public Screening
The Guangzhou Colorectal Cancer Summit Forum and the 22nd Guangdong Provincial Colorectal Cancer Academic Conference were successfully held from August 5-10, 2024. Reporters from Oncology Frontier conducted an in-depth interview with the conference chair, Dr. Gong Chen from the Sun Yat-sen University Cancer Center, focusing on the highlights of the conference and the precision diagnosis…
-
B J Hepatol | Xiaolong Qi / Jie Shen: High Prevalence o+f Liver Fibrosis in the General Population of China
On July 28, 2024, the Journal of Hepatology (CAS 1st Tier, IF: 26.8), a leading international journal in hepatology, published a prospective study conducted by the LiverHome research group. This study, based on the general population in China, assessed the prevalence of fatty liver disease and liver fibrosis, providing the latest evidence for chronic liver…
-
Hepatol Int | Higher Risk of Liver-Related Mortality in Lean MAFLD Patients Compared to Non-Lean Patients
While metabolic-associated fatty liver disease (MAFLD) has traditionally been associated with obesity and metabolic syndrome, recent studies indicate that a significant prevalence of MAFLD also exists among lean individuals. These patients typically do not exhibit traditional obesity-related risk factors, such as a high body mass index (BMI) or large waist circumference, yet their livers are…
Connecting Medical Expertise through Media